Table 3 Major CRS + HIPEC characteristics of MPM patients between PS and non-PS groups
From: Risk factors and prognosis of malignant peritoneal mesothelioma with paraneoplastic syndrome
Variables | Non-PS group (n = 86) | PS group (n = 60) | P value |
|---|---|---|---|
PCI, n (%) | 0.049 | ||
≤ 20 | 35 (40.7) | 15 (25.0) | |
> 20 | 51 (59.3) | 45 (75.0) | |
CC, n (%) | < 0.001 | ||
0–1 | 58 (67.4) | 22 (36.7) | |
2–3 | 28 (32.6) | 38 (63.3) | |
RBC transfusion (U), n (%) | 0.167 | ||
< 5 | 70 (81.4) | 43 (71.7) | |
≥ 5 | 16 (18.6) | 17 (28.3) | |
Resected organs, n (%) | 0.825 | ||
≤ 2 | 56 (65.1) | 38 (63.3) | |
> 2 | 30 (34.9) | 22 (36.7) | |
Resected peritoneal areas, n (%) | 0.704 | ||
≤ 5 | 40 (46.5) | 26 (43.3) | |
> 5 | 46 (53.5) | 34 (56.7) | |
Ascites (mL), n (%) | 0.003 | ||
0 | 25 (29.1) | 10 (16.7) | |
0–1000 | 34 (39.5) | 14 (23.3) | |
> 1000 | 27 (31.4) | 36 (60.0) | |